FibrobiologicsFBLG

13F holders, Q4 2025 (December 31)
46holders −9
6new positions
15sold out
3famous investors
$0.22avg. 13F price*

At the end of Q4 2025, 46 institutions reported holding Fibrobiologics Inc. (FBLG) in their 13F filings, down 9 from Q3 2025. 6 opened new positions and 15 sold out. The largest holders were Vanguard Group Inc. ($274K), BlackRock, Inc. ($108K) and Geode Capital Management, LLC ($78K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).

Company
Fibrobiologics Inc.
CUSIP
31573L105
Latest filing quarter
Q4 2025

History

Number of 13F holders

020406080 Q1 2024: 17Q1 2024Q2 2024: 50Q2 2024Q3 2024: 61Q3 2024Q4 2024: 64Q4 2024Q1 2025: 65Q1 2025Q2 2025: 58Q2 2025Q3 2025: 55Q3 2025Q4 2025: 46Q4 2025

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions6$85K
Exits15$1.1M

All 13F filers, Q3 2025 → Q4 2025: 726,477 shares bought and 1,702,169 shares sold, net −975,692 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 46 holders

Vanguard Group Inc. 0.00% Reduce -1.4% 1,216,341 $274K
BlackRock, Inc. 0.00% Add +9.7% 482,401 $108K
Geode Capital Management, LLC 0.00% Add +20.7% 348,761 $78K
Cascade Financial Partners, LLC 0.01% Add +5.5% 314,581 $71K
Millennium Management 0.00% Reduce -35.3% 288,496 $65K
Renaissance Technologies 0.00% Add +287.3% 231,600 $52K
Jane Street Group, LLC 0.00% New 149,763 $34K
AMG National Trust Bank 0.00% New 138,960 $31K
UBS Group AG 0.00% Add +56.0% 120,770 $27K
State Street Corp. 0.00% No change 111,300 $25K
Optivise Advisory Services LLC 0.01% No change 110,100 $25K
Requisite Capital Management, LLC 0.00% No change 109,713 $25K
&partners 0.00% No change 100,000 $22K
Cerity Partners LLC 0.00% Reduce -25.4% 93,919 $21K
American Institute for Advanced Investment Management, LLP 0.01% No change 88,206 $20K
Saxon Interests, Inc. 0.00% Add +38.3% 57,000 $13K
Bank of America Corp. 0.00% Add +0.0% 48,176 $11K
Northern Trust Corp. 0.00% No change 47,674 $11K
RMR Wealth Builders 0.00% No change 38,360 $9K
XTX Topco Ltd 0.00% New 37,919 $9K
Concurrent Investment Advisors, LLC 0.00% No change 35,283 $8K
DRW Securities, LLC 0.00% New 33,348 $7K
Ethos Financial Group, LLC 0.00% No change 24,424 $5K
Raymond James Financial Inc. 0.00% No change 18,642 $4K
Tower Research Capital LLC (TRC) 0.00% Add +6.8% 18,109 $4K
Cetera Investment Advisers 0.00% No change 18,006 $4K
NewEdge Advisors, LLC 0.00% No change 16,906 $4K
Qube Research & Technologies Ltd 0.00% Reduce -43.8% 16,836 $4K
Flaharty Asset Management, LLC 0.00% No change 14,702 $3K
Cahaba Wealth Management, Inc. 0.00% No change 14,702 $3K
Point72 Asset Management 0.00% New 14,476 $3K
Brooklyn Investment Group 0.00% No change 11,500 $3K
Goldman Sachs Group Inc. 0.00% No change 10,468 $2K
Global Assets Advisory, LLC 0.00% Reduce -2.3% 10,450 $2K
CWA Asset Management Group, LLC 0.00% No change 10,000 $2K
Osaic Holdings, Inc. 0.00% Reduce -25.0% 6,000 $1K
Islay Capital Management, LLC 0.00% No change 3,391 $763
Grove Bank & Trust 0.00% No change 2,000 $450
Disciplined Equity Management, Inc. 0.00% New 1,000 $418
BNP Paribas Financial Markets 0.00% No change 1,306 $294
Allworth Financial LP 0.00% No change 261 $59
Wells Fargo & Company 0.00% No change 200 $45
Optiver Holding B.V. 0.00% No change 26 $6
Deutsche Bank AG 0.00% No change 18 $4
Barclays PLC 0.00% No change 1 $0
Royal Bank of Canada 0.00% Reduce -8.4% 1,842 $0

"% of holder's portfolio" is FBLG's weight in each manager's 13F, not the share of Fibrobiologics Inc. the manager owns.